Skip to content

HSHS St. Elizabeth’s Hospital first in Metro East to use Multipoint Pacing technology for heart patients


BELLEVILLE – HSHS St. Elizabeth’s Hospital, in partnership with Prairie Cardiovascular Consultants, is the first facility in the Metro East to utilize the new MultiPoint Pacing technology, featured on the Quadra Allure MP CRT-pacemaker. Prairie cardiologist Dr. Atul Shah performed the procedure recently in the multi-million-dollar electrophysiology lab at the Belleville campus.

MultiPoint pacing technology is designed to deliver electrical pulses to multiple locations within the left side of the heart to resynchronize contraction of the heart’s lower chambers (ventricles). It may also increase a heart failure patient’s response to cardiac resynchronization therapy (CRT) by increasing the amount of cardiac tissue being stimulated at one time and may reduce the need for costly and invasive procedures to readjust the placement of the thin wires, called leads, around the heart.

According to the American Heart Association, CRT can improve the heart’s efficiency at pumping blood to the body and can lessen symptoms of heart failure, including shortness of breath. However, even with effective placement of the leads around the heart, therapy can be unpredictable and ineffective for some patients. The goal of MultiPoint Pacing technology is to allow physicians to program the device to capture more left-ventricular tissue at one time by pacing at multiple locations in the heart, increasing the number of patients who benefit from this type of therapy.

“St. Elizabeth’s is committed to providing region leading high-quality care, treatment and service through partnerships with excellent physicians, such as Dr. Atul Shah and those of Prairie Cardiovascular Consultants, and in our continued investment in state-of-the-art technologies for improved patient outcomes,” said Peg Sebastian, St. Elizabeth’s Hospital president and chief executive officer. “We are excited to be the only facility in the metro east region to offer this advanced cardiovascular treatment.”

Approximately 23 million people worldwide are afflicted with congestive heart failure and 2 million new cases are diagnosed worldwide each year. Studies have shown that CRT can improve the quality of life for many patients with heart failure, a progressive condition in which the heart weakens and loses its ability to pump an adequate supply of blood. CRT resynchronizes the lower chambers (ventricles) of the heart by sending uniquely programmed electrical impulses to stimulate each ventricle to beat in sync for optimal cardiac performance.

Despite the improvements seen with quadripolar CRT technology, non-responders to therapy remain a significant issue. Also, non-responders to CRT are not able to be identified at the time of implant and individual patient response can be unpredictable. Previous studies have shown that activating more ventricular tissue faster may enhance heart muscle performance.

MultiPoint Pacing technology, from global medical device manufacturer St. Jude Medical, is approved by the U.S. Food and Drug Administration for commercial use in the U.S. For more information, visit

— From the Illinois Business Journal

Leave a Comment